- Conditions: Pediatrics; Muscle Spasticity
Interventions: Biological: botulinum toxin Type A; Biological: botulinum toxin Type A; Drug: Normal Saline (Placebo)
Sponsors: Allergan; Allergan
Not yet recruiting - verified May 2012 - Conditions: Pediatrics; Muscle Spasticity
Interventions: Biological: botulinum toxin Type A; Biological: botulinum toxin Type A; Drug: Normal Saline (Placebo)
Sponsors: Allergan; Allergan
Not yet recruiting - verified May 2012 - Conditions: Pediatrics; Muscle Spasticity
Intervention: Biological: botulinum toxin Type A
Sponsors: Allergan; Allergan
Not yet recruiting - verified May 2012 - Conditions: Pediatrics; Muscle Spasticity
Intervention: Biological: botulinum toxin Type A
Sponsors: Allergan; Allergan
Not yet recruiting - verified May 2012 - Conditions: Urinary Incontinence; Multiple Sclerosis
Interventions: Biological: OnabotulinumtoxinA; Drug: Placebo (Normal Saline); OnabotulinumtoxinA
Sponsors: Allergan; Allergan
Not yet recruiting - verified May 2012 - Conditions: Breast Cancer; Pain, Postoperative; BRCA1 Mutation; BRCA2 Mutation; Breast Diseases; Neoplasms
Interventions: Drug: Botulinum Toxin Type A; Drug: Sodium Chloride Solution
Sponsors: Mayo Clinic; Mayo Clinic
Not yet recruiting - verified May 2012 - Conditions: Nocturia; Benign Prostatic Hyperplasia; Incontinence
Interventions: Drug: onaBoNT-A + placebo; Drug: Tamsulosin + placebo
Sponsors: Baylor College of Medicine; Baylor College of Medicine; Department of Veterans Affairs
Not yet recruiting - verified May 2012 - Conditions: Skin Aging; Elastosis Senilis
Intervention: Biological: incobotulinumtoxinA
Sponsors: The Maas Clinic; The Maas Clinic; Merz Pharmaceuticals, LLC
Recruiting - verified April 2012 - Conditions: Endometriosis; Botulinum Toxin A; Chronic Pelvic Pain; Pelvic Muscle Spasms; Quality of Life
Intervention: Drug: Botuninum toxin A
Sponsors: National Institutes of Health Clinical Center (CC); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified August 2011 - Conditions: Prostate Cancer; Benign Prostatic Hyperplasia; Enlarged Prostate With Lower Urinary Tract Symptoms (LUTS)
Intervention: Drug: BOTOX
Sponsors: Baylor College of Medicine; Baylor College of Medicine
Recruiting - verified January 2012 - Condition: Migraine Disorders
Intervention: Biological: onabotulinumtoxinA
Sponsors: Allergan; Allergan
Recruiting - verified May 2012 - Condition: Refractory Urge Urinary Incontinence
Interventions: Device: InterStim® device; Drug: Botox® injection
Sponsors: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Duke University; University of Alabama at Birmingham; University of California, San Diego; The Cleveland Clinic; Brown University; University of New Mexico; University of Pennsylvania; University of Pittsburgh; Oregon Health and Science University; RTI International
Recruiting - verified February 2012 - Condition: Cervical Dystonia
Intervention: Biological: Xeomin®
Sponsors: Merz Pharmaceuticals, LLC; Merz Pharmaceuticals, LLC
Recruiting - verified May 2012 - Conditions: Ischemia; Vasopressor
Intervention: Drug: Injection of botulinum toxin A
Sponsors: Duke University; Duke University
Recruiting - verified May 2012 - Condition: Wrinkles
Interventions: Drug: Botulinum Toxin Type A; Procedure: Chemical Facial Peel
Sponsors: Loyola University; Loyola University
Recruiting - verified April 2012 - Condition: Damage Control Laparotomy
Interventions: Drug: Botulinum Toxin Type A; Drug: Placebo
Sponsors: Mayo Clinic; Mayo Clinic
Recruiting - verified December 2011 - Condition: Post-stroke Spasticity of the Lower Limb.
Interventions: Drug: IncobotulinumtoxinA (400 Units); Drug: Placebo Comparator
Sponsors: Merz Pharmaceuticals GmbH; Merz Pharmaceuticals GmbH
Recruiting - verified May 2012 - Condition: Scar
Interventions: Drug: Dysport (abobotulinumtoxinA); Drug: Bacteriostatic 0.9% Sodium Chloride (vehicle)
Sponsors: AboutSkin Dermatology and DermSurgery, PC; AboutSkin Dermatology and DermSurgery, PC; University Hospitals of Cleveland; Medicis Pharmaceutical Corporation
Recruiting - verified January 2012 - Condition: Stroke With Hemiparesis
Intervention: Drug: Botulinum Toxin commonly known as BOTOX®
Sponsors: New York University School of Medicine; New York University School of Medicine; Allergan
Recruiting - verified April 2012 - Conditions: Stroke; Muscle Spasticity
Intervention: Drug: Botox (botulinum toxin)
Sponsors: Weill Medical College of Cornell University; Weill Medical College of Cornell University
Recruiting - verified March 2012 - Condition: Depression
Interventions: Drug: Clostridium botulinum toxin type A neurotoxin complex; Other: 0.9% NaCl solution
Sponsors: Seton Family of Hospitals; Seton Family of Hospitals
Recruiting - verified May 2012 - Condition: Neuroma
Interventions: Drug: onabotulinum toxin type-A; Other: placebo; Drug: 2nd phase - onabotulinum toxin type-A
Sponsors: Southern Illinois University; Southern Illinois University
Not yet recruiting - verified February 2012 - Conditions: Lateral Canthal Lines; Crow's Feet
Interventions: Biological: ANT-1207; Biological: Botulinum Toxin, Type A; Biological: Botulinum Toxin Type A
Sponsors: Anterios Inc.; Anterios Inc.
Recruiting - verified January 2012 - Condition: Flu-like Symptoms
Intervention:
Sponsors: Baylor College of Medicine; Christine Hunter; Merz Pharmaceuticals, LLC
Recruiting - verified February 2012 - Condition: Nervous System Disorders
Interventions: Drug: Botulinum type A toxin (Dysport®); Drug: Placebo
Sponsors: Ipsen; Ipsen
Recruiting - verified April 2012 - Condition: Raynaud's Disease
Intervention: Drug: onabotulinum toxin type-A
Sponsors: Southern Illinois University; Southern Illinois University
Recruiting - verified April 2012 - Condition: Acne Vulgaris
Intervention: Biological: ANT-1207
Sponsors: Anterios Inc.; Anterios Inc.
Recruiting - verified January 2012 - Conditions: Cervical Dystonia; Blepharospasm
Intervention: Biological: Xeomin®
Sponsors: Merz Pharmaceuticals, LLC; Merz Pharmaceuticals, LLC; Registrat-Mapi
Recruiting - verified May 2012 - Condition: Epiphora
Interventions: Drug: Botulinum Toxin Type A; Drug: Botulinum Toxin Type A
Sponsors: Merbs, Shannath, M.D., Ph.D.; Merbs, Shannath, M.D., Ph.D.
Recruiting - verified July 2011 - Conditions: Cerebral Palsy; Muscle Spasticity; Children
Interventions: Drug: Botulinum type A toxin (Dysport®); Drug: Placebo
Sponsors: Ipsen; Ipsen
Recruiting - verified March 2012 - Conditions: Cerebral Palsy; Muscle Spasticity; Children
Intervention: Drug: Botulinum type A toxin (Dysport®)
Sponsors: Ipsen; Ipsen
Recruiting - verified March 2012 - Condition: Leg Spasticity
Interventions: Drug: Botulinum type A toxin (Dysport®); Drug: Placebo
Sponsors: Ipsen; Ipsen
Recruiting - verified April 2012 - Condition: Herpes Labialis
Interventions: Drug: onabotulinumtoxinA; Other: Bacteriostatic normal saline
Sponsors: DeNova Research; DeNova Research; Allergan
Recruiting - verified June 2011 - Conditions: Torticollis; Cervical Dystonia
Intervention: Drug: Botulinum Toxin A
Sponsors: Henry Ford Health System; Henry Ford Health System; Allergan
Recruiting - verified June 2011 - Conditions: Cutaneous Leiomyomas; Hereditary Leiomyomatosis and Renal Cell Cancer
Interventions: Biological: Botulinum toxin type A; Other: Placebo
Sponsors: National Institutes of Health Clinical Center (CC); National Cancer Institute (NCI)
Recruiting - verified May 2012 - Condition: Bruxism
Intervention: Drug: Botulinum toxin type A
Sponsors: Baylor College of Medicine; Baylor College of Medicine; Allergan
Recruiting - verified September 2010 - Conditions: Spasmodic Dysphonia; Dystonia
Intervention: Behavioral: Vocal Exercise
Sponsors: New York University School of Medicine; New York University School of Medicine; Allergan
Recruiting - verified July 2011 - Condition: Cervical Dystonia
Intervention: Biological: Botulinum toxin type A
Sponsors: Allergan; Allergan
Recruiting - verified April 2012 - Condition: Psoriasis Vulgaris
Interventions: Procedure: injection of botulinum toxin type A.; Procedure: normal saline
Sponsors: University of Minnesota - Clinical and Translational Science Institute; University of Minnesota - Clinical and Translational Science Institute
Recruiting - verified July 2011 - Condition: Peyronie's Disease
Interventions: Drug: 100 units of BOTOX®; Other: Preservative free normal saline
Sponsors: Baylor College of Medicine; Mohit Khera; Allergan
Recruiting - verified December 2011 - Condition: Pain
Interventions: Drug: Botulinum Toxin A; Drug: Placebo - Saline
Sponsors: Stanford University; Stanford University
Recruiting - verified September 2011 - Condition: Carpal Tunnel Syndrome
Interventions: Drug: Botulinum toxin; Drug: Corticosteroid injection into Carpal Tunnel
Sponsors: University of Minnesota - Clinical and Translational Science Institute; University of Minnesota - Clinical and Translational Science Institute
Not yet recruiting - verified November 2010 - Investigation of Efficacy and Safety of Botulinum Toxin A (Botox-Allergan Inc) in Migraine HeadachesCondition: Refractory Migraine
Interventions: Drug: Botulinum toxin A; Drug: Botulinum toxin A
Sponsors: Yale University; Yale University
Recruiting - verified August 2011 - Condition: Overactive Bladder
Interventions: Biological: botulinum toxin Type A 200U; Biological: botulinum toxin Type A 300U; Biological: placebo; botulinum Toxin Type A 200U; Biological: Placebo; botulinum toxin Type A 300U
Sponsors: Allergan; Allergan
Recruiting - verified December 2011 - Condition: Cerebral Palsy
Interventions: Procedure: Upper Extremity Tendon transfer; Procedure: Botulinum Toxin injections in Upper Extremity; Procedure: Regularly ongoing therapy
Sponsors: Shriners Hospitals for Children; Shriners Hospitals for Children
Recruiting - verified January 2012 - Conditions: Chorea; Drug Induced Dyskinesia; Movement Disorder; Muscular Disease; Tic Disorder
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified September 2011
 |
Botulinum Clinical Trials |
